Tellgen Corporation (SHE:300642)
China flag China · Delayed Price · Currency is CNY
18.50
-1.22 (-6.19%)
Oct 19, 2026, 3:04 PM CST

Tellgen Company Description

Tellgen Corporation research, development, production, and sales of in-vitro diagnostic products in China and internationally.

The company offers fully automatic flow fluorescence analyzer and CLIA analyzer; molecular test such as HPV test, lung cancer, colon cancer, personalized medicine, and infertility; and automatic integrated gene detection systems.

It also provides tumor detection products; HPV nucleic acid testing products; methylation mutation detection products; detection products for invasive fungal diseases.

The company was founded in 2003 and is based in Shanghai, China.

Tellgen Corporation
CountryChina
Founded2003
IndustryMedical Devices
SectorHealthcare
Employees683
CEOJian Er Yao

Contact Details

Address:
No. 412 Huiqing Road
Shanghai, 201201
China
Phone86 21 5086 2711
Websitetellgen.com

Stock Details

Ticker Symbol300642
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100002P42
SIC Code3841

Key Executives

NamePosition
Jian Er YaoNon-Independent Chairman of Board and GM
Songtao LiFinancial Manager and Accounting Supervisor
En Huan YangDeputy GM and Non-Independent Director
Xiaoqing WangDeputy GM, Secretary of Board of Directors, Director of GM's Office and Non-Independent Director
Ye ShengDirector of Research & Development and Deputy GM